artificial intelligence has become an important role in the medical field. Machine learning
based on medical imaging
plays a significant complementary role in clinical decision-making. Moreover
the integration of imaging data with genomic information has introduced innovative avenues for genetic testing. The primary focus of this article was on the current state
limitations
and future trends of machine learning based on medical imaging for predicting epidermal growth factor receptor (
EGFR
) mutations in patients with non-small cell lung cancer (NSCLC).
Intelligent imaging for precision diagnosis and treatment of pancreatic tumors: current applications and future perspectives
Advances in the application of ultrasound artificial intelligence in prostate cancer
The predictive value of CT radiomics model for immunotherapy efficacy in non-small cell lung cancer
The application value of radiomics-based prediction of Bcl-2 and c-Myc expression status in patients with intracranial primary central nervous system lymphoma
Prediction of outcomes in patients with locally advanced cervical cancer after concurrent chemoradiotherapy based on machine learning-based radiomics
Related Author
TANG Wei
YUAN Xiaohan
YU Xianjun
TONG Tong
Wanjun JIANG
Zhen WANG
Yunxin ZHAO
Ying DONG
Related Institution
Department of Radiology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Ultrasound, Shanghai Punan Hospital of Pudong New District
College of Medical Instrumentation, Shanghai University of Medicine & Health Sciences
Department of Radiology, Huadong Hospital, Fudan University